

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 8.18854172 |
| 2 | melanin metabolic process (GO:0006582) | 7.56724850 |
| 3 | secondary metabolite biosynthetic process (GO:0044550) | 6.58129061 |
| 4 | regulation of T cell tolerance induction (GO:0002664) | 5.56624303 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.49064003 |
| 6 | eosinophil chemotaxis (GO:0048245) | 5.33588585 |
| 7 | positive regulation of tolerance induction (GO:0002645) | 5.31144561 |
| 8 | regulation of tolerance induction (GO:0002643) | 4.95455736 |
| 9 | eosinophil migration (GO:0072677) | 4.70701238 |
| 10 | regulation of regulatory T cell differentiation (GO:0045589) | 4.63764451 |
| 11 | sphingosine metabolic process (GO:0006670) | 4.04983442 |
| 12 | regulation of memory T cell differentiation (GO:0043380) | 4.04248228 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.73574634 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.73504575 |
| 15 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66159342 |
| 16 | regulation of translational termination (GO:0006449) | 3.63501089 |
| 17 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.48605011 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.47514965 |
| 19 | melanosome organization (GO:0032438) | 3.43988395 |
| 20 | response to thyroid hormone (GO:0097066) | 3.42416511 |
| 21 | developmental pigmentation (GO:0048066) | 3.40637619 |
| 22 | tyrosine metabolic process (GO:0006570) | 3.33275988 |
| 23 | pigment granule organization (GO:0048753) | 3.31684482 |
| 24 | response to muscle activity (GO:0014850) | 3.28748193 |
| 25 | cellular response to ethanol (GO:0071361) | 3.27602042 |
| 26 | pyrimidine-containing compound salvage (GO:0008655) | 3.27530130 |
| 27 | pyrimidine nucleoside salvage (GO:0043097) | 3.27530130 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24289809 |
| 29 | diol metabolic process (GO:0034311) | 3.21646546 |
| 30 | negative regulation of defense response to virus (GO:0050687) | 3.20883849 |
| 31 | response to type I interferon (GO:0034340) | 3.18896032 |
| 32 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.18144214 |
| 33 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.16475565 |
| 34 | proteasome assembly (GO:0043248) | 3.15603582 |
| 35 | cellular response to type I interferon (GO:0071357) | 3.11663330 |
| 36 | type I interferon signaling pathway (GO:0060337) | 3.11663330 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07009934 |
| 38 | pigment biosynthetic process (GO:0046148) | 3.02707690 |
| 39 | negative regulation of viral entry into host cell (GO:0046597) | 2.95297129 |
| 40 | negative regulation of response to biotic stimulus (GO:0002832) | 2.95217819 |
| 41 | positive regulation of lymphocyte migration (GO:2000403) | 2.90260960 |
| 42 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.79364078 |
| 43 | hyaluronan catabolic process (GO:0030214) | 2.77839818 |
| 44 | sphingoid metabolic process (GO:0046519) | 2.77465018 |
| 45 | mRNA cleavage (GO:0006379) | 2.76112331 |
| 46 | necroptotic process (GO:0070266) | 2.72703972 |
| 47 | pigment metabolic process (GO:0042440) | 2.72403446 |
| 48 | regulation of superoxide anion generation (GO:0032928) | 2.71798748 |
| 49 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.68899885 |
| 50 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.68842569 |
| 51 | regulation of lymphocyte migration (GO:2000401) | 2.62891047 |
| 52 | regulation of oxidative phosphorylation (GO:0002082) | 2.58389791 |
| 53 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.56548898 |
| 54 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.54457839 |
| 55 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.53837158 |
| 56 | hypotonic response (GO:0006971) | 2.52832605 |
| 57 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.50987884 |
| 58 | negative regulation of interleukin-12 production (GO:0032695) | 2.47037261 |
| 59 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.46924551 |
| 60 | mitotic G2/M transition checkpoint (GO:0044818) | 2.43417267 |
| 61 | immunoglobulin mediated immune response (GO:0016064) | 2.40526664 |
| 62 | phenol-containing compound biosynthetic process (GO:0046189) | 2.39173375 |
| 63 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.38214254 |
| 64 | regulation of superoxide metabolic process (GO:0090322) | 2.38030224 |
| 65 | negative regulation of organelle assembly (GO:1902116) | 2.36703329 |
| 66 | regulation of macrophage chemotaxis (GO:0010758) | 2.36147298 |
| 67 | coenzyme catabolic process (GO:0009109) | 2.34970752 |
| 68 | positive regulation of natural killer cell activation (GO:0032816) | 2.32576786 |
| 69 | B cell mediated immunity (GO:0019724) | 2.32004001 |
| 70 | positive regulation of interleukin-12 production (GO:0032735) | 2.30525932 |
| 71 | regulation of coenzyme metabolic process (GO:0051196) | 2.28335707 |
| 72 | regulation of cofactor metabolic process (GO:0051193) | 2.28335707 |
| 73 | galactose metabolic process (GO:0006012) | 2.26512731 |
| 74 | response to peptidoglycan (GO:0032494) | 2.25750084 |
| 75 | detection of molecule of bacterial origin (GO:0032490) | 2.24168847 |
| 76 | pigment cell differentiation (GO:0050931) | 2.22043719 |
| 77 | T cell migration (GO:0072678) | 2.21657081 |
| 78 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.21528853 |
| 79 | mast cell activation (GO:0045576) | 2.19633562 |
| 80 | regulation of viral entry into host cell (GO:0046596) | 2.19365046 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.19339532 |
| 82 | regulation of mononuclear cell migration (GO:0071675) | 2.19004132 |
| 83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.18417908 |
| 84 | AMP metabolic process (GO:0046033) | 2.15670260 |
| 85 | regulation of interleukin-12 production (GO:0032655) | 2.14292654 |
| 86 | nucleoside salvage (GO:0043174) | 2.13598441 |
| 87 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.12873753 |
| 88 | positive regulation of T cell mediated immunity (GO:0002711) | 2.12690611 |
| 89 | regulation of sulfur metabolic process (GO:0042762) | 2.12438623 |
| 90 | phagocytosis, recognition (GO:0006910) | 2.12045069 |
| 91 | response to interferon-alpha (GO:0035455) | 2.11878147 |
| 92 | melanocyte differentiation (GO:0030318) | 2.10110838 |
| 93 | cofactor catabolic process (GO:0051187) | 2.09356539 |
| 94 | oxaloacetate metabolic process (GO:0006107) | 2.08730425 |
| 95 | response to protozoan (GO:0001562) | 2.08044201 |
| 96 | positive regulation of T cell migration (GO:2000406) | 2.07809076 |
| 97 | regulation of T cell migration (GO:2000404) | 2.06912476 |
| 98 | TOR signaling (GO:0031929) | 2.06711087 |
| 99 | mitotic chromosome condensation (GO:0007076) | 2.06181202 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.04678534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.98547645 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47858940 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.41286310 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.52945904 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.10121493 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87606905 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54779598 |
| 8 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49739471 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48421804 |
| 10 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.23455539 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.20468095 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07732443 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86847035 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.82812535 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.81270908 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76098453 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.73020639 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.68390269 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68159647 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.68144415 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65400248 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63123805 |
| 23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.61932091 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.52566660 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.50322564 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.49054659 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48124720 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47553218 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47470386 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46640500 |
| 31 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45931500 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44955338 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.42563524 |
| 34 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39162130 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.37637744 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.37466716 |
| 37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35496747 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33260916 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32787031 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.32282142 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32019408 |
| 42 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27441218 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26778436 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26202428 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25172656 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25172656 |
| 47 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24834433 |
| 48 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23274419 |
| 49 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22602415 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22048171 |
| 51 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21424631 |
| 52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19765642 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18544511 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16418508 |
| 55 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15834721 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14292462 |
| 57 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14184699 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08260681 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06753570 |
| 60 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.05984571 |
| 61 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.05836045 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.05740454 |
| 63 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03889623 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01608690 |
| 65 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.01556860 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00255162 |
| 67 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.00219816 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.99089778 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 0.98911454 |
| 70 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98658346 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.97545669 |
| 72 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.97376203 |
| 73 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96025934 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95646334 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95602106 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93813233 |
| 77 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.91632853 |
| 78 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91169926 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89986390 |
| 80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89935438 |
| 81 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89620290 |
| 82 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89239966 |
| 83 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88288560 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.87253393 |
| 85 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.87192727 |
| 86 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86642149 |
| 87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.86489478 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.84755727 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.84724996 |
| 90 | MAF_26560356_Chip-Seq_TH1_Human | 0.84392523 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83965906 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.83737001 |
| 93 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.83719187 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83704968 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83368870 |
| 96 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.83113170 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81932349 |
| 98 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.80903977 |
| 99 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80197942 |
| 100 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.78643353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000372_irregular_coat_pigmentation | 6.16041812 |
| 2 | MP0005408_hypopigmentation | 4.43807788 |
| 3 | MP0005171_absent_coat_pigmentation | 4.24812342 |
| 4 | MP0003136_yellow_coat_color | 4.11628755 |
| 5 | MP0004381_abnormal_hair_follicle | 3.91513603 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 3.77222195 |
| 7 | MP0000015_abnormal_ear_pigmentation | 3.59158863 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.37041269 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 3.05961880 |
| 10 | MP0000371_diluted_coat_color | 2.63978409 |
| 11 | MP0005174_abnormal_tail_pigmentation | 2.49929517 |
| 12 | MP0002095_abnormal_skin_pigmentation | 2.18791119 |
| 13 | MP0001835_abnormal_antigen_presentation | 1.85273004 |
| 14 | MP0003172_abnormal_lysosome_physiology | 1.82152492 |
| 15 | MP0005058_abnormal_lysosome_morphology | 1.74421180 |
| 16 | MP0003646_muscle_fatigue | 1.64089914 |
| 17 | MP0002090_abnormal_vision | 1.59411382 |
| 18 | MP0004233_abnormal_muscle_weight | 1.58247989 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.56935180 |
| 20 | MP0000569_abnormal_digit_pigmentation | 1.54176520 |
| 21 | MP0005671_abnormal_response_to | 1.49511969 |
| 22 | MP0003950_abnormal_plasma_membrane | 1.49501861 |
| 23 | MP0005451_abnormal_body_composition | 1.45722845 |
| 24 | MP0002075_abnormal_coat/hair_pigmentati | 1.45577067 |
| 25 | MP0001324_abnormal_eye_pigmentation | 1.43227873 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.41896841 |
| 27 | MP0009785_altered_susceptibility_to | 1.39976181 |
| 28 | MP0003186_abnormal_redox_activity | 1.38215875 |
| 29 | MP0000749_muscle_degeneration | 1.36209178 |
| 30 | MP0001851_eye_inflammation | 1.35472122 |
| 31 | MP0003195_calcinosis | 1.33326757 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.32206424 |
| 33 | MP0009840_abnormal_foam_cell | 1.27055512 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.25783696 |
| 35 | MP0001186_pigmentation_phenotype | 1.25059892 |
| 36 | MP0002132_abnormal_respiratory_system | 1.24288603 |
| 37 | MP0004084_abnormal_cardiac_muscle | 1.23248152 |
| 38 | MP0005387_immune_system_phenotype | 1.22871670 |
| 39 | MP0001790_abnormal_immune_system | 1.22871670 |
| 40 | MP0003111_abnormal_nucleus_morphology | 1.19432776 |
| 41 | MP0002419_abnormal_innate_immunity | 1.17903244 |
| 42 | MP0000343_altered_response_to | 1.16607033 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.15820164 |
| 44 | MP0000685_abnormal_immune_system | 1.13962576 |
| 45 | MP0003693_abnormal_embryo_hatching | 1.13076131 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.12968667 |
| 47 | MP0010234_abnormal_vibrissa_follicle | 1.12691463 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.12298609 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.11958844 |
| 50 | MP0001800_abnormal_humoral_immune | 1.11932999 |
| 51 | MP0002102_abnormal_ear_morphology | 1.11688818 |
| 52 | MP0006082_CNS_inflammation | 1.11231727 |
| 53 | MP0004272_abnormal_basement_membrane | 1.09284576 |
| 54 | MP0009697_abnormal_copulation | 1.09085899 |
| 55 | MP0005000_abnormal_immune_tolerance | 1.08284487 |
| 56 | MP0005025_abnormal_response_to | 1.07805708 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.04729912 |
| 58 | MP0002723_abnormal_immune_serum | 1.02032378 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 0.97696069 |
| 60 | MP0002420_abnormal_adaptive_immunity | 0.97544592 |
| 61 | MP0001819_abnormal_immune_cell | 0.97292633 |
| 62 | MP0005360_urolithiasis | 0.95925492 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.92481552 |
| 64 | MP0003077_abnormal_cell_cycle | 0.89565530 |
| 65 | MP0001661_extended_life_span | 0.89555176 |
| 66 | MP0005670_abnormal_white_adipose | 0.88832184 |
| 67 | MP0008057_abnormal_DNA_replication | 0.87253342 |
| 68 | MP0005330_cardiomyopathy | 0.86851822 |
| 69 | MP0001845_abnormal_inflammatory_respons | 0.85901181 |
| 70 | MP0003878_abnormal_ear_physiology | 0.83762644 |
| 71 | MP0005377_hearing/vestibular/ear_phenot | 0.83762644 |
| 72 | MP0002269_muscular_atrophy | 0.82600952 |
| 73 | MP0005197_abnormal_uvea_morphology | 0.81805159 |
| 74 | MP0004484_altered_response_of | 0.78952876 |
| 75 | MP0000678_abnormal_parathyroid_gland | 0.77659039 |
| 76 | MP0002998_abnormal_bone_remodeling | 0.77560800 |
| 77 | MP0002398_abnormal_bone_marrow | 0.74609230 |
| 78 | MP0003045_fibrosis | 0.73981483 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.73582359 |
| 80 | MP0000716_abnormal_immune_system | 0.73341176 |
| 81 | MP0003786_premature_aging | 0.73211565 |
| 82 | MP0008058_abnormal_DNA_repair | 0.72401250 |
| 83 | MP0005164_abnormal_response_to | 0.71572521 |
| 84 | MP0002405_respiratory_system_inflammati | 0.70370048 |
| 85 | MP0000920_abnormal_myelination | 0.70251322 |
| 86 | MP0002722_abnormal_immune_system | 0.67400130 |
| 87 | MP0002396_abnormal_hematopoietic_system | 0.66883815 |
| 88 | MP0008469_abnormal_protein_level | 0.66734457 |
| 89 | MP0002429_abnormal_blood_cell | 0.66429679 |
| 90 | MP0004957_abnormal_blastocyst_morpholog | 0.65920789 |
| 91 | MP0003436_decreased_susceptibility_to | 0.65821674 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 0.65707465 |
| 93 | MP0008007_abnormal_cellular_replicative | 0.65577320 |
| 94 | MP0000689_abnormal_spleen_morphology | 0.64084309 |
| 95 | MP0008260_abnormal_autophagy | 0.60426889 |
| 96 | MP0003315_abnormal_perineum_morphology | 0.60024814 |
| 97 | MP0000703_abnormal_thymus_morphology | 0.60009525 |
| 98 | MP0009764_decreased_sensitivity_to | 0.59727301 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.59352288 |
| 100 | MP0009763_increased_sensitivity_to | 0.58480856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ocular albinism (HP:0001107) | 5.79802327 |
| 2 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.84207874 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.82830482 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.82830482 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.82830482 |
| 6 | Iris hypopigmentation (HP:0007730) | 4.77079604 |
| 7 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.43361964 |
| 8 | Albinism (HP:0001022) | 4.20162942 |
| 9 | Cutaneous melanoma (HP:0012056) | 4.15246374 |
| 10 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.82532507 |
| 11 | Hypoplasia of the fovea (HP:0007750) | 3.82532507 |
| 12 | Pustule (HP:0200039) | 3.80415670 |
| 13 | Cholecystitis (HP:0001082) | 3.79378317 |
| 14 | Abnormal gallbladder physiology (HP:0012438) | 3.79378317 |
| 15 | Blue irides (HP:0000635) | 3.61184214 |
| 16 | Generalized hypopigmentation (HP:0007513) | 3.58791878 |
| 17 | White forelock (HP:0002211) | 3.42112963 |
| 18 | Poor head control (HP:0002421) | 3.25592821 |
| 19 | Patchy hypopigmentation of hair (HP:0011365) | 3.25419346 |
| 20 | Abnormality of the fovea (HP:0000493) | 3.22922897 |
| 21 | Freckling (HP:0001480) | 3.08971522 |
| 22 | Glomerulonephritis (HP:0000099) | 2.82234099 |
| 23 | Abnormal auditory evoked potentials (HP:0006958) | 2.77389984 |
| 24 | Hypopigmentation of the fundus (HP:0007894) | 2.67389087 |
| 25 | Premature graying of hair (HP:0002216) | 2.64471734 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.63465595 |
| 27 | Vascular calcification (HP:0004934) | 2.51779238 |
| 28 | Horizontal nystagmus (HP:0000666) | 2.51644912 |
| 29 | Hyporeflexia of lower limbs (HP:0002600) | 2.47168340 |
| 30 | Myocardial infarction (HP:0001658) | 2.43644327 |
| 31 | Squamous cell carcinoma (HP:0002860) | 2.34721069 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 2.34686219 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32035493 |
| 34 | Abnormality of glycolysis (HP:0004366) | 2.25824912 |
| 35 | Recurrent bacterial skin infections (HP:0005406) | 2.23602539 |
| 36 | Autoimmune hemolytic anemia (HP:0001890) | 2.20621537 |
| 37 | Recurrent abscess formation (HP:0002722) | 2.19366011 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.18030231 |
| 39 | Colitis (HP:0002583) | 2.17923962 |
| 40 | Vacuolated lymphocytes (HP:0001922) | 2.17505162 |
| 41 | Chromsome breakage (HP:0040012) | 2.17234426 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.16784798 |
| 43 | Reduced antithrombin III activity (HP:0001976) | 2.12455878 |
| 44 | Retrobulbar optic neuritis (HP:0100654) | 2.09826422 |
| 45 | Optic neuritis (HP:0100653) | 2.09826422 |
| 46 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.06504309 |
| 47 | Granulocytopenia (HP:0001913) | 2.04908712 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.03823034 |
| 49 | Orchitis (HP:0100796) | 1.99109599 |
| 50 | Entropion (HP:0000621) | 1.97689968 |
| 51 | Onycholysis (HP:0001806) | 1.95459665 |
| 52 | Generalized hypopigmentation of hair (HP:0011358) | 1.95418269 |
| 53 | Prolonged partial thromboplastin time (HP:0003645) | 1.95216758 |
| 54 | Abnormality of the preputium (HP:0100587) | 1.94294049 |
| 55 | Enlarged kidneys (HP:0000105) | 1.92955776 |
| 56 | T lymphocytopenia (HP:0005403) | 1.91235751 |
| 57 | Aplasia cutis congenita (HP:0001057) | 1.89777730 |
| 58 | Abnormality of T cell number (HP:0011839) | 1.89541235 |
| 59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.89387188 |
| 60 | Keratoconjunctivitis sicca (HP:0001097) | 1.85971687 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 1.84128957 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.84128957 |
| 63 | Ileus (HP:0002595) | 1.83033494 |
| 64 | Poikiloderma (HP:0001029) | 1.81637931 |
| 65 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81345422 |
| 66 | Dysostosis multiplex (HP:0000943) | 1.81013027 |
| 67 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.80919387 |
| 68 | Increased serum pyruvate (HP:0003542) | 1.80815225 |
| 69 | Melanoma (HP:0002861) | 1.79254364 |
| 70 | Eosinophilia (HP:0001880) | 1.79012798 |
| 71 | Fatigue (HP:0012378) | 1.78395390 |
| 72 | Hypoplasia of the iris (HP:0007676) | 1.76888943 |
| 73 | Decreased central vision (HP:0007663) | 1.74742265 |
| 74 | Abnormal platelet function (HP:0011869) | 1.73748485 |
| 75 | Impaired platelet aggregation (HP:0003540) | 1.73748485 |
| 76 | Nonimmune hydrops fetalis (HP:0001790) | 1.73586485 |
| 77 | Abnormality of macrophages (HP:0004311) | 1.71952241 |
| 78 | Abnormality of the alveolar ridges (HP:0006477) | 1.71537947 |
| 79 | Joint hemorrhage (HP:0005261) | 1.71531722 |
| 80 | Cholelithiasis (HP:0001081) | 1.68906732 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68484423 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68484423 |
| 83 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.67812110 |
| 84 | Polycythemia (HP:0001901) | 1.67809664 |
| 85 | Abnormality of the ileum (HP:0001549) | 1.66146325 |
| 86 | Recurrent skin infections (HP:0001581) | 1.66016397 |
| 87 | Myositis (HP:0100614) | 1.64592014 |
| 88 | Birth length less than 3rd percentile (HP:0003561) | 1.63936359 |
| 89 | Lower limb hyperreflexia (HP:0002395) | 1.62236514 |
| 90 | Slow saccadic eye movements (HP:0000514) | 1.62127570 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.61790327 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.61790327 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.61790327 |
| 94 | Axonal loss (HP:0003447) | 1.60785374 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 1.60773348 |
| 96 | Abnormality of T cells (HP:0002843) | 1.60684417 |
| 97 | Abnormality of chromosome stability (HP:0003220) | 1.60081883 |
| 98 | Thyroid-stimulating hormone excess (HP:0002925) | 1.59233366 |
| 99 | Gangrene (HP:0100758) | 1.59095700 |
| 100 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.58652470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK3 | 4.09145085 |
| 2 | BLK | 3.51024332 |
| 3 | MAP3K3 | 3.38396688 |
| 4 | WEE1 | 2.96510333 |
| 5 | LATS1 | 2.92047711 |
| 6 | BRSK1 | 2.77262738 |
| 7 | NEK2 | 2.74863503 |
| 8 | SIK3 | 2.59853384 |
| 9 | PINK1 | 2.59175430 |
| 10 | MST1R | 2.56734662 |
| 11 | NME2 | 2.40384190 |
| 12 | LATS2 | 2.09233155 |
| 13 | EIF2AK3 | 1.86648736 |
| 14 | WNK4 | 1.83594048 |
| 15 | EIF2AK1 | 1.74157535 |
| 16 | BUB1 | 1.62406238 |
| 17 | IRAK3 | 1.60995682 |
| 18 | MELK | 1.53502542 |
| 19 | BRSK2 | 1.45046291 |
| 20 | TYK2 | 1.44969394 |
| 21 | TXK | 1.44763463 |
| 22 | ADRBK2 | 1.39708319 |
| 23 | STK39 | 1.34004599 |
| 24 | MYLK | 1.33950398 |
| 25 | TAOK3 | 1.30891021 |
| 26 | MAPK11 | 1.24074118 |
| 27 | PBK | 1.23059643 |
| 28 | KSR1 | 1.20456409 |
| 29 | TRIM28 | 1.18480979 |
| 30 | MAP4K1 | 1.18101047 |
| 31 | CCNB1 | 1.17832542 |
| 32 | STK38L | 1.16735637 |
| 33 | PDK2 | 1.16267561 |
| 34 | MAP3K14 | 1.14837261 |
| 35 | STK3 | 1.14391568 |
| 36 | ZAP70 | 1.11928286 |
| 37 | GRK6 | 1.11726585 |
| 38 | CLK1 | 1.08975168 |
| 39 | STK38 | 1.06825807 |
| 40 | WNK1 | 1.05251256 |
| 41 | TGFBR2 | 1.03945028 |
| 42 | MAP3K2 | 1.03397293 |
| 43 | FGR | 0.94713968 |
| 44 | PTK2B | 0.93543961 |
| 45 | ERN1 | 0.89116389 |
| 46 | JAK1 | 0.88174492 |
| 47 | MAP3K1 | 0.87858781 |
| 48 | TRPM7 | 0.87654451 |
| 49 | MAP3K8 | 0.84563653 |
| 50 | STK10 | 0.83994825 |
| 51 | MAP3K13 | 0.81872558 |
| 52 | ACVR1B | 0.79152521 |
| 53 | IRAK2 | 0.77539744 |
| 54 | BMPR2 | 0.76881016 |
| 55 | IKBKE | 0.76602512 |
| 56 | PRPF4B | 0.76202195 |
| 57 | CDC42BPA | 0.72286875 |
| 58 | BTK | 0.71928429 |
| 59 | STK4 | 0.71872638 |
| 60 | JAK3 | 0.71752996 |
| 61 | PAK4 | 0.70692488 |
| 62 | PRKCQ | 0.68771991 |
| 63 | BCR | 0.66040038 |
| 64 | TBK1 | 0.64655931 |
| 65 | CDK3 | 0.63629323 |
| 66 | OBSCN | 0.63266054 |
| 67 | FGFR4 | 0.62816583 |
| 68 | TTK | 0.60548599 |
| 69 | TAOK2 | 0.56485578 |
| 70 | ARAF | 0.54607963 |
| 71 | MST4 | 0.53399425 |
| 72 | BMPR1B | 0.52267072 |
| 73 | CDK7 | 0.48898027 |
| 74 | SYK | 0.48659291 |
| 75 | MET | 0.48258830 |
| 76 | AURKB | 0.47621032 |
| 77 | MAP2K3 | 0.47485821 |
| 78 | IKBKB | 0.47437390 |
| 79 | RIPK4 | 0.46661569 |
| 80 | MAPKAPK2 | 0.46650426 |
| 81 | PIK3CG | 0.46364180 |
| 82 | FER | 0.45038768 |
| 83 | CDC7 | 0.44652352 |
| 84 | CSNK1A1L | 0.43141868 |
| 85 | LYN | 0.42720771 |
| 86 | FGFR3 | 0.42265650 |
| 87 | KSR2 | 0.41720861 |
| 88 | AKT2 | 0.41107990 |
| 89 | CSK | 0.40225804 |
| 90 | MUSK | 0.37719008 |
| 91 | PIM1 | 0.37501896 |
| 92 | MAPKAPK3 | 0.36828755 |
| 93 | NLK | 0.35874464 |
| 94 | ATR | 0.35520376 |
| 95 | PLK1 | 0.35169517 |
| 96 | EGFR | 0.34692884 |
| 97 | ATM | 0.34514555 |
| 98 | IGF1R | 0.34096618 |
| 99 | EIF2AK2 | 0.33648895 |
| 100 | PRKAA2 | 0.29950599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31331946 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.12880383 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.06043945 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.89055263 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.66450583 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.59844424 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.58773845 |
| 8 | Viral myocarditis_Homo sapiens_hsa05416 | 2.18155054 |
| 9 | Proteasome_Homo sapiens_hsa03050 | 2.08716733 |
| 10 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.03207473 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.01005446 |
| 12 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.95593845 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85264821 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85154633 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71947755 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64402677 |
| 17 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.60672471 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.58484705 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52802447 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.51010959 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.50135925 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47451707 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.43528317 |
| 24 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.42424240 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36510667 |
| 26 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.34798264 |
| 27 | DNA replication_Homo sapiens_hsa03030 | 1.26448232 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.25904266 |
| 29 | Homologous recombination_Homo sapiens_hsa03440 | 1.19878461 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.17754602 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17727185 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.16615103 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16400196 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15763667 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.14578100 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.11101650 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08825867 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.07068888 |
| 39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06948319 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.05774518 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.04920552 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04211367 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04055115 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 1.02906859 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01131022 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98873813 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.98364717 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.98353362 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.96372877 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93512356 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91102635 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89885138 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.89559519 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.89243617 |
| 55 | Legionellosis_Homo sapiens_hsa05134 | 0.88809620 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87458977 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79823508 |
| 58 | Malaria_Homo sapiens_hsa05144 | 0.78431857 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76414158 |
| 60 | Cell cycle_Homo sapiens_hsa04110 | 0.74950275 |
| 61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74055734 |
| 62 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72186039 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.69994051 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69740452 |
| 65 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.69672162 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68629138 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67696544 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66396278 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64902443 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61675671 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.59747731 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.59683067 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.57405677 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56294051 |
| 75 | Mismatch repair_Homo sapiens_hsa03430 | 0.53826005 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53601056 |
| 77 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.52821741 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52551152 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51666742 |
| 80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50118096 |
| 81 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48250840 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47530559 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.46128968 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45844467 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44810625 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43644715 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.43182573 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42606806 |
| 89 | Hepatitis C_Homo sapiens_hsa05160 | 0.41425496 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40758438 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40616577 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36368019 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.35323096 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.34669282 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34302831 |
| 96 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.33941994 |
| 97 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33113246 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.32450418 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.30537931 |
| 100 | Olfactory transduction_Homo sapiens_hsa04740 | 0.29998411 |

